AKUMS - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.7
| Stock Code | AKUMS | Market Cap | 7,566 Cr. | Current Price | 481 ₹ | High / Low | 623 ₹ |
| Stock P/E | 59.6 | Book Value | 151 ₹ | Dividend Yield | 0.00 % | ROCE | 16.2 % |
| ROE | 13.2 % | Face Value | 2.00 ₹ | DMA 50 | 466 ₹ | DMA 200 | 485 ₹ |
| Chg in FII Hold | -1.13 % | Chg in DII Hold | 5.13 % | PAT Qtr | 31.0 Cr. | PAT Prev Qtr | 23.5 Cr. |
| RSI | 52.9 | MACD | 4.27 | Volume | 1,00,257 | Avg Vol 1Wk | 1,60,722 |
| Low price | 405 ₹ | High price | 623 ₹ | PEG Ratio | 1.74 | Debt to equity | 0.02 |
| 52w Index | 35.0 % | Qtr Profit Var | -24.7 % | EPS | 7.88 ₹ | Industry PE | 27.6 |
📊 Chart & Trend: Current price (481 ₹) is trading slightly above 50 DMA (466 ₹) but near 200 DMA (485 ₹), reflecting a neutral-to-bullish undertone. Support lies near 466–470 ₹, resistance at 485–500 ₹.
📉 Momentum Indicators: RSI at 52.9 indicates balanced momentum, neither overbought nor oversold. MACD at 4.27 confirms mild bullish strength. Bollinger Bands show price moving toward the mid-to-upper band, suggesting consolidation with upward bias.
📈 Volume Trends: Current volume (1.00 lakh) is below the 1-week average (1.60 lakh), showing weak participation. Sustained breakout requires stronger volume confirmation.
🎯 Entry Zone: 465–480 ₹ (near 50 DMA support, favorable risk-reward).
🎯 Exit Zone: 495–510 ₹ (near 200 DMA resistance; profit booking advisable).
🔎 Trend Status: The stock is consolidating with mild bullish bias. Technicals show stability, but volume weakness limits breakout potential.
Positive
- ROCE (16.2%) and ROE (13.2%) reflect decent capital efficiency.
- Debt-to-equity ratio at 0.02 indicates near debt-free status.
- DII holding increased (+5.13%), showing strong domestic institutional support.
Limitation
- High P/E (59.6) compared to industry average (27.6) suggests overvaluation.
- PEG ratio at 1.74 indicates valuation stretched relative to growth.
- Quarterly profit variance (-24.7%) shows earnings inconsistency.
Company Negative News
- Decline in FII holding (-1.13%) signals reduced foreign investor confidence.
- Quarterly PAT slipped (31 Cr vs 23.5 Cr) with volatility in earnings.
Company Positive News
- DII holding surged (+5.13%), reflecting strong domestic institutional confidence.
- EPS at 7.88 ₹ highlights steady earnings base.
- 52-week performance (35% index gain) shows resilience.
Industry
- Industry PE at 27.6 suggests moderate sector valuation.
- Pharmaceutical and healthcare manufacturing sector benefits from rising demand and regulatory support.
Conclusion
⚖️ AKUMS is consolidating with mild bullish bias, trading near key moving averages. Entry near 465–480 ₹ offers tactical opportunity, with exit targets around 495–510 ₹. Fundamentals show decent efficiency and strong DII support, but valuations remain stretched and earnings volatility is a concern. Best suited for cautious swing trades with stop-loss near 465 ₹.
Would you like me to prepare a pharma sector basket overlay with peer benchmarking, so you can see how AKUMS stacks up against other mid-cap pharma players for rotation opportunities?